13F HOLDINGS REPORT
Ally Bridge Group (NY) LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0000950123-23-004992
Total Value
$76.3M
Positions
18
Other Managers
1
Confidential Omitted
No
Holdings (18)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VERONA PHARMA PLC | 925050106 | 487,631 | $9.8M | 12.83% |
| 2 | XENON PHARMACEUTICALS INC | XENE | 266,961 | $9.6M | 12.52% |
| 3 | BELLUS HEALTH INC NEW | 07987C204 | 1,131,827 | $8.1M | 10.68% |
| 4 | CYTOKINETICS INC | CYTK | 223,382 | $7.9M | 10.30% |
| 5 | MADRIGAL PHARMACEUTICALS INC | MDGL | 29,614 | $7.2M | 9.40% |
| 6 | IVERIC BIO INC | 46583P102 | 255,310 | $6.2M | 8.14% |
| 7 | MERUS NV | N5749R100 | 275,970 | $5.1M | 6.66% |
| 8 | MERSANA THERAPEUTICS INC | 59045L106 | 1,191,271 | $4.9M | 6.42% |
| 9 | JASPER THERAPEUTICS INC | JSPRW | 2,517,232 | $4.6M | 5.97% |
| 10 | SAREPTA THERAPEUTICS INC | SRPT | 20,830 | $2.9M | 3.76% |
| 11 | CTI BIOPHARMA CORP | 12648L601 | 550,000 | $2.3M | 3.03% |
| 12 | MEDAVAIL HOLDINGS INC | 58406B103 | 5,894,897 | $1.7M | 2.21% |
| 13 | MDXHEALTH SA | MDXH | 500,000 | $1.6M | 2.12% |
| 14 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 72,850 | $1.6M | 2.04% |
| 15 | RAPID MICRO BIOSYSTEMS INC | RPID | 699,664 | $916,560 | 1.20% |
| 16 | ESSA PHARMA INC | 29668H708 | 236,583 | $702,652 | 0.92% |
| 17 | KINNATE BIOPHARMA INC | 49705R105 | 109,393 | $683,706 | 0.90% |
| 18 | SYROS PHARMACEUTICALS INC | 87184Q206 | 249,126 | $665,166 | 0.87% |